BofA Merrill Lynch, UBS Finance $5.5B Lonza Acquisition of Capsugel
Swiss biotechnology company Lonza will acquire Capsugel for $5.5 billion, including refinancing of existing Capsugel debt of $2 billion. Bank of America Merrill Lynch and UBS have committed financing to support the transaction.
December 15, 2016
Bank of America Merrill Lynch | Capsugel | Lonza | UBS
ABF Journal